tetano
Editor, Senior Moderator
Paediatr Child Health. 2013 Oct;18(8):e51-2.
Influenza vaccine recommendations for children and youth for the 2013/2014 season.
[Article in English, French]
Moore DL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee.
Abstract
in English, French
Recommendations from the National Advisory Committee on Immunization concerning indications for the routine influenza vaccination of children and their close contacts have not changed from those of 2012/2013. Intranasal, live attenuated influenza vaccine (LAIV) is preferred over trivalent inactivated influenza vaccines (TIV) for healthy children and youth. There is insufficient evidence to recommend LAIV over TIV in children with chronic health conditions; either may be used unless there are specific contraindications. TIV may be used in persons with egg allergy; LAIV has not yet been evaluated in this population and is not recommended at this time.
KEYWORDS:
Children, Influenza vaccine, LAIV, TIV
PMID:
24426802
[PubMed]
PMCID:
PMC3887090
[Available on 2014/10/1]
http://www.ncbi.nlm.nih.gov/pubmed/24426802
Influenza vaccine recommendations for children and youth for the 2013/2014 season.
[Article in English, French]
Moore DL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee.
Abstract
in English, French
Recommendations from the National Advisory Committee on Immunization concerning indications for the routine influenza vaccination of children and their close contacts have not changed from those of 2012/2013. Intranasal, live attenuated influenza vaccine (LAIV) is preferred over trivalent inactivated influenza vaccines (TIV) for healthy children and youth. There is insufficient evidence to recommend LAIV over TIV in children with chronic health conditions; either may be used unless there are specific contraindications. TIV may be used in persons with egg allergy; LAIV has not yet been evaluated in this population and is not recommended at this time.
KEYWORDS:
Children, Influenza vaccine, LAIV, TIV
PMID:
24426802
[PubMed]
PMCID:
PMC3887090
[Available on 2014/10/1]
http://www.ncbi.nlm.nih.gov/pubmed/24426802